Showing 1 to 12 of 18 results


EU Faces Record Shortages of Essential Medicines
A new report from the European Court of Auditors reveals critical shortages of 136 essential medicines in the EU between 2022 and October 2024, reaching record highs in 2023 and 2024 with 48 and 46 critical shortages respectively, impacting 21 out of 27 member states.
EU Faces Record Shortages of Essential Medicines
A new report from the European Court of Auditors reveals critical shortages of 136 essential medicines in the EU between 2022 and October 2024, reaching record highs in 2023 and 2024 with 48 and 46 critical shortages respectively, impacting 21 out of 27 member states.
Progress
8% Bias Score


US Pharmaceutical Tariffs Threaten Drug Shortages and Higher Prices
The imminent expiration of a 90-day pause on U.S. import duties threatens to impose tariffs on imported pharmaceuticals, potentially violating WTO rules, causing higher prices for brand-name drugs and exacerbating existing generic drug shortages, especially of antibiotics and chemotherapy treatments...
US Pharmaceutical Tariffs Threaten Drug Shortages and Higher Prices
The imminent expiration of a 90-day pause on U.S. import duties threatens to impose tariffs on imported pharmaceuticals, potentially violating WTO rules, causing higher prices for brand-name drugs and exacerbating existing generic drug shortages, especially of antibiotics and chemotherapy treatments...
Progress
48% Bias Score


Pharmacists Fear Drug Tariffs Will Worsen Shortages, Raise Prices
President Trump's proposed tariffs on imported pharmaceuticals are causing widespread concern among pharmacists, who worry that the tariffs will exacerbate existing drug shortages and drive up prices, particularly for independent pharmacies operating on razor-thin margins.
Pharmacists Fear Drug Tariffs Will Worsen Shortages, Raise Prices
President Trump's proposed tariffs on imported pharmaceuticals are causing widespread concern among pharmacists, who worry that the tariffs will exacerbate existing drug shortages and drive up prices, particularly for independent pharmacies operating on razor-thin margins.
Progress
48% Bias Score


Trump's Pharmaceutical Tariffs Threaten Drug Shortages
President Trump's planned tariffs on pharmaceutical imports are raising concerns about drug shortages and price increases, impacting generic drug manufacturers significantly, with a 270-day investigation underway to assess national security implications.
Trump's Pharmaceutical Tariffs Threaten Drug Shortages
President Trump's planned tariffs on pharmaceutical imports are raising concerns about drug shortages and price increases, impacting generic drug manufacturers significantly, with a 270-day investigation underway to assess national security implications.
Progress
48% Bias Score


Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, and Uncertain Domestic Production
President Trump announced major tariffs on pharmaceutical imports, expected to increase drug prices and worsen shortages, while the impact on domestic manufacturing remains debated and years away.
Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, and Uncertain Domestic Production
President Trump announced major tariffs on pharmaceutical imports, expected to increase drug prices and worsen shortages, while the impact on domestic manufacturing remains debated and years away.
Progress
48% Bias Score


France: Amoxicillin Shortages Ease After Reduced Antibiotic Prescriptions
Following a decrease in antibiotic prescriptions for winter illnesses in France, amoxicillin supplies have normalized, with the ANSM reporting sufficient quantities to meet patient needs after shortages in 2022; however, some amoxicillin/clavulanic acid dosages remain limited, while clarithromycin s...
France: Amoxicillin Shortages Ease After Reduced Antibiotic Prescriptions
Following a decrease in antibiotic prescriptions for winter illnesses in France, amoxicillin supplies have normalized, with the ANSM reporting sufficient quantities to meet patient needs after shortages in 2022; however, some amoxicillin/clavulanic acid dosages remain limited, while clarithromycin s...
Progress
32% Bias Score

Family Office Investments Surge, Driven by Biotech
Family office investments surged to 60 deals in June 2025, up from 47 in May, with a notable focus on biotech, as seen in Antheia's \$56 million Series C round, aiming to improve drug access globally.

Family Office Investments Surge, Driven by Biotech
Family office investments surged to 60 deals in June 2025, up from 47 in May, with a notable focus on biotech, as seen in Antheia's \$56 million Series C round, aiming to improve drug access globally.
Progress
48% Bias Score

Kursk Health Official Sentenced for Drug Procurement Mismanagement
A former Kursk regional health committee chair was found guilty of abuse of office, causing drug shortages for vulnerable groups from October 26, 2020 to February 28, 2023, leading to health deterioration and a 24 million ruble budget loss, resulting in a three-year suspended sentence and a 100,000 ...

Kursk Health Official Sentenced for Drug Procurement Mismanagement
A former Kursk regional health committee chair was found guilty of abuse of office, causing drug shortages for vulnerable groups from October 26, 2020 to February 28, 2023, leading to health deterioration and a 24 million ruble budget loss, resulting in a three-year suspended sentence and a 100,000 ...
Progress
52% Bias Score

Trump's Executive Order Targets High Prescription Drug Prices
President Trump signed an executive order on May 12th aiming to lower U.S. prescription drug prices by tying them to the lowest prices in comparable developed countries, potentially saving Americans 50-90% on medication costs, but facing legal and implementation challenges and risking drug shortages...

Trump's Executive Order Targets High Prescription Drug Prices
President Trump signed an executive order on May 12th aiming to lower U.S. prescription drug prices by tying them to the lowest prices in comparable developed countries, potentially saving Americans 50-90% on medication costs, but facing legal and implementation challenges and risking drug shortages...
Progress
40% Bias Score

Trump's Prescription Drug Tariffs: Potential for Higher Costs and Shortages
President Trump's plan to impose tariffs on prescription drugs, announced this week, aims to boost domestic production but risks increasing drug prices by an estimated $600 per household annually and worsening existing drug shortages, according to experts.

Trump's Prescription Drug Tariffs: Potential for Higher Costs and Shortages
President Trump's plan to impose tariffs on prescription drugs, announced this week, aims to boost domestic production but risks increasing drug prices by an estimated $600 per household annually and worsening existing drug shortages, according to experts.
Progress
52% Bias Score

Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, Uncertain Production Boost
President Trump's announcement of major tariffs on pharmaceutical imports aims to boost domestic drug manufacturing but may instead increase drug prices and shortages, impacting patient access to essential medicines, with any increase in US production years away.

Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, Uncertain Production Boost
President Trump's announcement of major tariffs on pharmaceutical imports aims to boost domestic drug manufacturing but may instead increase drug prices and shortages, impacting patient access to essential medicines, with any increase in US production years away.
Progress
52% Bias Score

EU's Critical Medicines Act Unveiled Amidst Concerns Over Drug Shortages
The European Commission's Critical Medicines Act aims to tackle chronic drug shortages by overhauling procurement rules, promoting joint purchasing, and providing €88.5 million in subsidies, but faces criticism for insufficient funding and weak stockpiling measures.

EU's Critical Medicines Act Unveiled Amidst Concerns Over Drug Shortages
The European Commission's Critical Medicines Act aims to tackle chronic drug shortages by overhauling procurement rules, promoting joint purchasing, and providing €88.5 million in subsidies, but faces criticism for insufficient funding and weak stockpiling measures.
Progress
44% Bias Score
Showing 1 to 12 of 18 results